Retirement Systems of Alabama trimmed its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 2.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 15,523 shares of the biotechnology company’s stock after selling 366 shares during the period. Retirement Systems of Alabama’s holdings in Axon Enterprise were worth $4,010,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently modified their holdings of AXON. BKM Wealth Management LLC bought a new position in shares of Axon Enterprise during the 4th quarter worth approximately $32,000. Key Financial Inc lifted its holdings in shares of Axon Enterprise by 367.6% in the 4th quarter. Key Financial Inc now owns 159 shares of the biotechnology company’s stock worth $41,000 after purchasing an additional 125 shares in the last quarter. Lindbrook Capital LLC grew its position in Axon Enterprise by 43.3% in the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company’s stock valued at $44,000 after purchasing an additional 52 shares during the period. Rakuten Securities Inc. bought a new stake in Axon Enterprise during the 4th quarter valued at $48,000. Finally, Provence Wealth Management Group acquired a new position in Axon Enterprise during the third quarter worth $80,000. 79.08% of the stock is currently owned by institutional investors.
Axon Enterprise Stock Up 2.9 %
AXON opened at $327.64 on Tuesday. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The company’s 50-day moving average price is $309.95 and its two-hundred day moving average price is $266.41. The stock has a market cap of $24.72 billion, a price-to-earnings ratio of 142.45 and a beta of 0.91. The company has a quick ratio of 2.66, a current ratio of 3.00 and a debt-to-equity ratio of 0.42.
Analysts Set New Price Targets
Several equities research analysts have recently commented on AXON shares. Barclays boosted their target price on shares of Axon Enterprise from $296.00 to $308.00 and gave the stock an “overweight” rating in a research report on Thursday, February 29th. StockNews.com downgraded Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th. Robert W. Baird lifted their target price on Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a research report on Thursday, February 22nd. Argus started coverage on Axon Enterprise in a research report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price target for the company. Finally, William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Wednesday, April 24th. Two analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $323.09.
Get Our Latest Research Report on Axon Enterprise
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- What Investors Need to Know About Upcoming IPOs
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- 3 REITs to Buy and Hold for the Long Term
- 3 Value Stocks You Can Buy Before They Become Big
- CD Calculator: Certificate of Deposit Calculator
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.